Latest Asx News

Macmahon Holdings has posted record FY25 results, buoyed by Decmil integration and strong mining contract wins, while raising its FY26 revenue and earnings guidance.

Amplitude Energy has delivered record production and earnings in FY25, driven by operational improvements and a strategic joint venture for the East Coast Supply Project.

Challenger Limited has announced a fully franked ordinary dividend of AUD 0.15 per share for the half-year ending June 2025, accompanied by a Dividend Reinvestment Plan with no discount.

Region Group has reported a strong FY25 with a $212.5 million net profit and raised its FY26 earnings guidance, underpinned by portfolio expansion and increased funds under management.

Region Group delivered a robust FY25 with a $212.5 million statutory profit driven by property revaluations, steady distributions, and strong portfolio metrics. The REIT also advanced sustainability goals and announced CEO retirement plans, setting the stage for strategic continuity.

Monadelphous Group Limited reported a robust 12% revenue increase to $2.27 billion and a 35% rise in net profit, driven by strong demand across resources and energy sectors and a record $2.5 billion in new contracts.

Challenger Limited reported a robust FY25 with a 9% rise in normalised profit and a strategic push into digital transformation and retirement income solutions.

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

Monadelphous Group Limited has announced a fully franked ordinary dividend of AUD 0.39 per share for the half-year ending June 2025, alongside a Dividend Reinvestment Plan offering shareholders a flexible way to reinvest.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

Reliance Worldwide Corporation reports a solid 5.5% sales increase and a 13.5% rise in net profit for FY25, boosted by the Holman acquisition, while cautioning on tariff impacts ahead.